关注
Jacques Brown
Jacques Brown
CHUL Research Centre
在 crchudequebec.ulaval.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial
ST Harris, NB Watts, HK Genant, CD McKeever, T Hangartner, M Keller, ...
Jama 282 (14), 1344-1352, 1999
32731999
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada
JP Brown, RG Josse, ...
Canadian Medical Association Journal 167 (10 suppl), S1-S34, 2002
17022002
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
KG Saag, R Emkey, TJ Schnitzer, JP Brown, F Hawkins, S Goemaere, ...
New England Journal of Medicine 339 (5), 292-299, 1998
15971998
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
JA Kanis, A Odén, O Johnell, H Johansson, C De Laet, J Brown, ...
Osteoporosis international 18 (8), 1033-1046, 2007
15162007
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus
AA Khan, A Morrison, DA Hanley, D Felsenberg, LK McCauley, F O'Ryan, ...
Journal of Bone and Mineral Research 30 (1), 3-23, 2015
14872015
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
A Papaioannou, S Morin, AM Cheung, S Atkinson, JP Brown, S Feldman, ...
Canadian Medical Association Journal 182 (17), 1864-1873, 2010
14182010
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy
D Liu, A Ahmet, L Ward, P Krishnamoorthy, ED Mandelcorn, R Leigh, ...
Allergy, Asthma & Clinical Immunology 9 (1), 30, 2013
12962013
Romosozumab in postmenopausal women with low bone mineral density
MR McClung, A Grauer, S Boonen, MA Bolognese, JP Brown, ...
New England Journal of Medicine 370 (5), 412-420, 2014
12792014
Intravenous zoledronic acid in postmenopausal women with low bone mineral density
IR Reid, JP Brown, P Burckhardt, Z Horowitz, P Richardson, U Trechsel, ...
New England Journal of Medicine 346 (9), 653-661, 2002
11292002
Canadian normative data for the SF-36 health survey
WM Hopman, T Towheed, T Anastassiades, A Tenenhouse, S Poliquin, ...
Canadian Medical Association Journal 163 (3), 265-271, 2000
9852000
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
JD Adachi, WG Bensen, J Brown, D Hanley, A Hodsman, R Josse, ...
New England Journal of Medicine 337 (6), 382-388, 1997
9461997
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
HG Bone, RB Wagman, ML Brandi, JP Brown, R Chapurlat, ...
The Lancet Diabetes & Endocrinology, 2017
9162017
Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 …
JP Brown, RL Prince, C Deal, RR Recker, DP Kiel, LH De Gregorio, ...
Journal of bone and mineral research 24 (1), 153-161, 2009
7972009
Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double‐blind, placebo‐controlled extension trial
JD Adachi, KG Saag, PD Delmas, UA Liberman, RD Emkey, E Seeman, ...
Arthritis & Rheumatology 44 (1), 202-211, 2001
7192001
A Meta‐Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX
EV McCloskey, A Odén, NC Harvey, WD Leslie, D Hans, H Johansson, ...
Journal of bone and mineral research 31 (5), 940-948, 2016
7012016
Recurrent Mutation of the Gene Encoding sequestosome 1 (SQSTM1/p62) in Paget Disease of Bone
N Laurin, JP Brown, J Morissette, V Raymond
The American Journal of Human Genetics 70 (6), 1582-1588, 2002
6532002
Vertebral Fractures Following Discontinuation of Denosumab: a Post‐hoc Analysis of the Randomized Placebo‐controlled FREEDOM Trial and its Extension
SR Cummings, S Ferrari, R Eastell, N Gilchrist, JE Beck Jensen, ...
Journal of Bone and Mineral Research, 2017
633*2017
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy
S Wallach, S Cohen, DM Reid, RA Hughes, DJ Hosking, RF Laan, ...
Calcified Tissue International 67 (4), 277-285, 2000
6182000
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
DL Kendler, C Roux, CL Benhamou, JP Brown, M Lillestol, S Siddhanti, ...
Journal of Bone and Mineral Research 25 (1), 72-81, 2010
5842010
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study
G Ioannidis, A Papaioannou, WM Hopman, N Akhtar-Danesh, ...
Canadian Medical Association Journal 181 (5), 265-271, 2009
5562009
系统目前无法执行此操作,请稍后再试。
文章 1–20